After Wei Kang ended the video conference, although he was very confident about reaching a settlement, he still felt uneasy.

He always felt that the other party seemed to be hiding something and secretly holding back his ultimate move.

One thing that puzzled him was why the other party was always willing to settle out of court. Is there a deeper meaning behind this?

If you just want money, wouldn't it be a better option to directly sue for compensation like other infringed companies?

Why do we have to negotiate peace with the Sanqing out of court again and again?

Why not just take $2 billion and walk away?

Could it be that the other party also needs the market for Sanqing’s thalassemia gene drugs?

So you don’t want to clear out early in the morning and quit completely?

After all, expanding the market, developing and maintaining patients consumes huge resources.

Although Sanqing has tightened the supply of genetic drugs during this period, the appointments and treatments for early patients have not been slowed down and are still being carried out in an orderly manner.

This information, coupled with previous clinical trial data, can serve as a valuable reference for latecomers.

As the saying goes, crossing the river by feeling the stones, since there are stones to touch, no one will let go of this opportunity for free prostitution.

Wei Kang pondered for a long time and finally solved his confusion.

But there was one more thing he still didn't understand.

This doesn’t seem to make sense. The Broad Institute is just a scientific research institution. Although it also has a biotechnology company under its name, it does not have the strength to develop large-scale clinical drugs.

unless?

Dry sticks caught fire.

Wei Kang's heart suddenly moved, and he remembered something that the other party's lawyer said unintentionally.

"...My client recently reached a cooperation agreement with Pfizer worth US$1.5 billion..."

That’s right! It’s Pfizer!

Wei Kang was instantly startled, and a layer of cold sweat broke out on his forehead.

He just thought that he was stalling for time, but he didn't expect that the other party was also having the same idea.

If Pfizer and the Broad Institute join forces to develop thalassemia gene drugs, then everything will make sense.

Just like the cooperation between Sanqing and Syngenta, one side produces genomic technology and the other side produces clinical medicine technology, forming a strong alliance.

The most important thing is that with the lone brave stone of Sanqing leading the way and crossing the river hand by hand, we can definitely make the same thalassemia gene medicine.

What? You said this is a generic drug?

However, the patent for gene editing technology is held by the Broad Institute.

As long as the big ban is used against Sanqing, it will be useless even if Sanqing registers a patent for the drug.

A crime of illegal infringement is enough to deprive a patent of its legality.

Pfizer can definitely make adjustments in the details, change its appearance, and return as the king of the original drug.

After Sanqing is kicked out, it will directly vacate the cage and change the bird, obtain all the developed patient resources, and occupy the entire market in one fell swoop.

This trick is so fucking brilliant!

The co-authored market was developed by Sanqing, the patients were treated by Sanqing, and the drugs were developed by Sanqing.

As a result, as soon as a big pot of patent infringement comes down, Sanqing will be banned and sent away.

All subsequent gains will be embraced by Pfizer and the Broad Institute, and they may even proudly curse you as a fool at the celebration banquet.

If he hadn't been the victim, Wei Kang couldn't help but applaud the opponent's wonderful operation.

Although this is all just speculation and has not been confirmed.

But Wei Kang knew that he couldn't wait any longer and had to take the initiative.

Since the other party has such an idea, it cannot be allowed to succeed.

It is inevitable for a strong man to cut off his wrist.

"Gan, let's just withdraw from the Eagle Kingdom market and fight to the death with you!"

Wei Kang felt angry and made a decision almost instantly.

At this moment, the phone suddenly rang.

At first glance, it was Tang Que's call.

I was connected immediately, and before I could say anything, I heard a burst of hearty laughter, and at the same time there was a noisy background sound, as if someone was yelling.

"Hahaha, boss, we succeeded!"

Tang Que's voice was extremely excited, and he shouted like a treasure: "We have discovered a new gene editing protease, boss, come here and take a look!"

"What? That's great! Someone gives me a pillow when I'm sleepy!"

call!

Wei Kang regained his energy, stood up, and ran downstairs to the genetic laboratory.

****

Meanwhile, Pfizer’s rare disease division.

A group of company executives and medical experts gathered together, all staring at the screen of the electron microscope in front of them.

The image above shows a cell culture dish.

Chief Scientific Officer Dorsten was wearing a white coat and was dancing with excitement.

"Gentlemen, this is a sample from a patient with thalassemia. Based on the base sequence of the target DNA, we prepared a guide RNA that can specifically bind to it, and combined it into the special CRISPR-provided by the Broad Institute.

In the cas9 plastid, a thalassemia gene drug was produced."

"We then infused the drug into the patient's blood stem cells, and something magical happened."

"The new hemoglobin has turned into a normal cake shape, and the hemoglobin concentration has also increased significantly. We can then implement clinical treatment on the patient."

"Believe me, when the results come out, we will have another strong player in our pharmaceutical family."

There was a burst of warm applause, and everyone was elated and overjoyed.

However, if Tang Que were here, he could easily find it.

The structure of the CRISPR-cas9 plasmid and guide RNA of this genetic drug looks very familiar, and it is almost the same model as Sanqing's genetic drug.

I can't say they are exactly the same, I can only say they are very similar.

****

Soon, Zheng Feng learned the good news.

The clinical trial of the first patient has also been successfully completed. The patient feels good after taking the drug and his hemoglobin index has returned to normal. Except for a few trivial adverse reactions, it can be said to be quite successful.

Next, Pfizer will conduct subsequent Phase I and Phase II clinical trials.

Since they have the clinical data of Sanqing before them, they will follow it accordingly without any problems.

"Very good."

Zheng Feng couldn't help but clenched his fists and waved them in the air a few times, feeling relaxed all over.

The cooperation with Pfizer finally bore fruit, and the Broad Institute also has its own blockbuster drug.

This is undoubtedly a major benefit to the promotion of CRISPR technology.

It is enough to prove that in addition to Sanqing, other companies can also make rapid breakthroughs in this area.

After completing the first and second phases of clinical trials, this genetic drug can immediately go through the fast-track application process and be launched on the market as soon as possible.

He has been coveting the vast market for thalassemia for a long time.

There are 350 million people in the world who carry the thalassemia gene, and the incidence rate in many high-incidence areas is as high as more than 10%, which means there are tens of millions of potential patients, and there are hundreds of thousands of severe patients.

If these severe patients can use Pfizer's genetic drugs.

If one sells for one million U.S. dollars, if 100,000 seriously ill patients can use it, it will cost hundreds of billions of U.S. dollars.

Even if there are only 10,000 seriously ill patients, that is 10 billion US dollars.

Zheng Feng did the math in his head and was instantly shocked by the number.

He couldn't help but hold his breath, and his heart was beating violently.

My whole mouth was dry and I was a little out of breath.

After a while, he regained his composure.

The next second, he jumped on his feet and dialed his subordinate's phone number.

"Immediately, immediately, notify the people at Sanqing to stop settlement negotiations, and at the same time ask the lawyer to submit a patent infringement lawsuit to the court immediately."

When he said this, the corners of his mouth tilted and his brows raised, with an uncontrollable look of pride on his face.

"I guess the expression on the face of that young rich man from China must have been wonderful when he heard the news!"
Chapter completed!